Why European Baby Formula Is Becoming a Top Choice for US Parents in 2026

How It Started: The 2022 Formula Shortage Changed Everything

The 2022 baby formula shortage is where this story really begins. In February 2022, Abbott Laboratories recalled several major formula brands following bacterial contamination at its Michigan manufacturing facility. The timing was terrible — post-pandemic supply chains were already strained. Out-of-stock rates hit nearly 70% in some states. Parents were rationing. Pediatricians were fielding calls they'd never trained for. It was a genuine public health emergency.

• 70% Out-of-stock rate in worst-hit states
• Feb 2022 Abbott Michigan facility recall
• Fly Formula Operation airlifting EU products in

The FDA's response included a move that permanently changed the US formula market: enforcement discretion. The agency temporarily allowed the import of European formulas that hadn't previously been cleared for sale in the US. President Biden's "Operation Fly Formula" physically airlifted Nestlé products from European facilities to fill empty American shelves.

For millions of US parents, this was the first time they'd ever fed their baby a European brand. And here's what nobody predicted: when the domestic shortage resolved, many of them didn't go back. They'd tried HiPP, Holle, and Kendamil during the crisis. They'd noticed something different about how their babies digested the food. The 2022 shortage was supposed to be a temporary workaround. It became a permanent preference shift.

FDA Approvals 2024–2026: European Brands Officially Enter the US Market

The crisis opened the door. Between 2024 and 2026, the FDA moved from emergency exceptions to permanent approvals for several European baby formula brands. This transition institutionalized the trend and gave parents the domestic recall protection they'd been missing.

1. Mid-2024
   Kendamil FDA approval
   First major UK brand on Target/Walmart shelves with full US retail status. The signal moment that ended grey-market dependence.
2. Late 2024
   Bubs Australia transitions to permanent FDA status
   Moved from emergency import authorization to full regulatory standing — proof the pipeline could work for non-EU foreign brands too.
3. 2024
   Bobbie launches European-inspired recipe
   A US-based brand built explicitly around European nutritional standards launches through domestic channels. The market shift is now visible from the inside.
4. 2025
   Kabrita — first FDA-approved goat milk formula
   Opens an entire specialty category — goat milk — to mainstream US distribution for the first time.
5. Early 2026
   Nannycare expands specialty goat options
   More options for sensitive infants enter mainstream availability. The "European formula = niche" narrative is officially over.

Kendamil's FDA approval in mid-2024 was the signal moment. A British formula — whole-milk-based, palm oil-free, built on European nutritional philosophy — landing full FDA retail status meant FDA-approved European baby formula was no longer a grey-market concept. It was aisle 7 at your local Target.

Bobbie took a different path: a US company that explicitly built its product around European nutritional standards — 60:40 whey-to-casein ratio, lactose as the sole carbohydrate, no corn syrup — and launched it through domestic channels. The fact that a US brand's biggest selling point was being "European-inspired" tells you everything about where parent preferences had moved.

Why the Trend Accelerated in 2025–2026: ByHeart, Nestlé, and Parent Confidence

The European formula trend in 2026 didn't just maintain momentum — it accelerated. Two specific events explain why:

• December 2025 The ByHeart Recall A brand marketed as premium, clean, and "what's wrong with domestic formula" was caught in a multi-state infant botulism outbreak. 28 confirmed cases, 20 probable cases across 19 states. It was the first known instance of infant botulism linked to formula in the US. For parents who had specifically chosen "new-age" American alternatives as their safety play, this was genuinely destabilizing. See our formula recall tracker for the current verified status across all major brands.
• December 2025 – Feb 2026 The Nestlé Cereulide Crisis A contaminated ARA oil supplier triggered recalls across 50+ countries. The European Food Safety Authority (EFSA) set the first-ever safety threshold for cereulide in infant formula within weeks of the crisis emerging. The US regulatory response was perceived as slower. For parents watching both events play out in real time, the comparative speed of European regulatory action became another data point in a decision they were already making.

Neither event made European baby formula's mainstream growth inevitable. But both reinforced a narrative that had been building for years: European regulatory frameworks move fast on new threats, and European formula ingredient standards set a high baseline.

What US Parents Are Actually Looking for in European Formula

US parents choose European formulas for specific, articulable reasons. Based on community conversations and parent surveys, four things come up consistently:

1. Lactose is the carbohydrate source The absence of corn syrup solids is the single most frequently cited reason US parents choose European formula. Many domestic "sensitive" brands use corn syrup or maltodextrin as their carbohydrate base. European formulas predominantly use lactose — the same sugar found in breast milk. Our ingredient comparison guide covers this in detail.
2. Mandatory DHA The EU has required DHA in all formulas since 2020. Under FDA rules, it remains optional. Most premium US brands add it anyway — but the regulatory baseline difference matters to parents doing ingredient research.
3. Stage-based nutrition US formulas are largely designed for 0–12 months as a single product. European brands stage the formula to the developmental window: Stage 1 for newborns, Stage 2 for 6–12 months, and Stage 3 for toddlers. Parents who've used both systems frequently report noticing the difference. Browse our European formula collection to see how the stages work across HiPP, Holle, and Kendamil.
4. Organic standards with meaning EU organic certification requires 95% organic ingredients plus a GMO ban with stricter contamination controls than USDA organic. Holle's Demeter biodynamic certification goes further still. For parents who've been deliberate about organic food choices for themselves, the stricter EU standard is a genuine draw — not just a label.

How US Parents Buy European Formula in 2026

European formula availability in the US has transformed since 2022. You no longer need a Facebook group or a customs prayer. In 2026, there are three real paths:

• Retail stores FDA-approved brands only
  Kendamil, Bobbie, and Kabrita are at major US retailers with full recall coverage. Buying European baby formula in US stores has become literal — no importer needed.
• Specialty importers HiPP, Holle, Lebenswert
  For HiPP, Holle, and other brands that haven't sought full FDA retail approval, specialist importers are the primary channel. Quality matters here: temperature-controlled shipping, verified sourcing, batch tracking, and proactive recall notification set a legitimate importer apart from a grey-market listing. Our shipping standards and weekly warehouse photos exist precisely because these things matter.
• Subscriptions Best value · No stockouts
  Most parents who commit to a European brand eventually move to subscription — the economics make sense (typically 10%+ savings), and the logistics of never running out are worth more than most parents realize until they've had a close call with an empty tin. See our subscription options if you're at that stage.

The Bottom Line: A Market Shift That's Here to Stay

The European formula trend in 2026 didn't emerge from a marketing campaign. It emerged from a crisis that forced millions of parents to try something different — and from the discovery that the ingredient profiles, the staging system, and the organic standards aligned with values they already held.

Why European baby formula has gone mainstream isn't complicated: parents read labels, noticed the differences, and made a choice. The FDA approval pipeline and the permanent changes in retail availability have removed the friction that once made that choice difficult.